Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

14 trials with published results (19%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

9.5%

7 terminated out of 74 trials

Success Rate

87.3%

+0.8% vs benchmark

Late-Stage Pipeline

4%

3 trials in Phase 3/4

Results Transparency

29%

14 of 48 completed with results

Key Signals

14 with results87% success

Data Visualizations

Phase Distribution

54Total
Not Applicable (24)
Early P 1 (1)
P 1 (9)
P 2 (17)
P 3 (2)
P 4 (1)

Trial Status

Completed48
Unknown8
Terminated7
Active Not Recruiting4
Recruiting3
Withdrawn2

Trial Success Rate

87.3%

Benchmark: 86.5%

Based on 48 completed trials

Clinical Trials (74)

Showing 20 of 20 trials
NCT02296684Phase 2CompletedPrimary

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

NCT02528955Phase 2CompletedPrimary

De-Intensification Radiotherapy Postoperative Head Neck

NCT04258813Not ApplicableActive Not Recruiting

Onco-primary Care Networking to Support TEAM-based Care

NCT03993353Phase 2Completed

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

NCT04617678Not ApplicableActive Not RecruitingPrimary

A Comprehensive Approach to Head and Neck Cancer Prehabilitation

NCT03894553Not ApplicableCompletedPrimary

Focused Ultrasound (FUS) Mesencephalotomy for Head & Neck Cancer Pain

NCT05316974CompletedPrimary

Lymphoedema Among Persons With Head- and Neck Cancer

NCT03383094Phase 2Active Not Recruiting

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

NCT04800419Not ApplicableCompletedPrimary

RCT of Effects of Mindfulness-based Stress Reduction in Head and Neck Cancer

NCT04356170Phase 2CompletedPrimary

Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma

NCT06995417Not Yet RecruitingPrimary

Discontinuation of Tobacco Dependence in Smoking Patients With Squamous Cell Carcinoma of the Head-neck District: Multicenter Prospective Observational Study

NCT05179824Active Not Recruiting

Tempus Priority Study: A Pan-tumor Observational Study

NCT04510129RecruitingPrimary

A Multicenter Cancer Biospecimen Collection Study

NCT05061316Not ApplicableCompletedPrimary

The Gut Microbiome As an Indicator of Readiness for Head & Neck Cancer Surgery

NCT02573493Phase 2Completed

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

NCT04658342TerminatedPrimary

Effects of Oral Cancer Treatments on Upper Esophageal Opening During Swallowing

NCT06630078Not ApplicableNot Yet Recruiting

Artificial Intelligence-based Voice Assessment of Children and Adults Respiratory Conditions

NCT06638762CompletedPrimary

Multi-Site Pathological Images-Guided ViT for Oral Squamous Cell Carcinoma Recurrence Prediction

NCT04767048Phase 2RecruitingPrimary

Interest of Bilateral Basic Tongue Mucosectomy Assisted by Robot or Laser in Combination with Tonsillectomy in the Assessment of Prevalent Cervical Lymphadenopathy

NCT01284348Phase 2Terminated

To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer

Scroll to load more

Research Network

Activity Timeline